CBLL — CeriBell, Inc.
CBLL dilution and offerings
- Active shelf: S-3 (Nov 2025)
- Float: 23.1M shares
🔔 Alert me if CBLL files an offering or S-3
$28.27+4.86%
Last close: · regular session
After-hours $23.50 -16.87% ·
Last 60 sessions
Active shelf registration (S-3, Nov 2025). Float: 23.1M shares. Latest SEC filing: 8-K on Nov 3, 2026. CBLL closed at $28.27 (+4.86%) on Nov 3, 2026.
Opening the full analysis uses 1 of your 3 free tickers today.
Chart, dilution, float and news for CBLL in the TickerWise workspace.
Company profile
- Sector: Healthcare
- Industry: Medical - Devices
- Country: US
- Exchange: NASDAQ
- Employees: 281
- Website: https://ceribell.com
CeriBell, Inc. develops AI based point-of-care electroencephalography (EEG) technology for the detection and treatment of neurological conditions. The company develops Ceribell System, a novel, point-of-care EEG platform to address the unmet needs of patients in the acute care setting. It also offers EEG disposable headbands; and pocket-sized battery-operated recorders. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. The company was incorporated in 2014 and is based in Sunnyvale, California.
Latest SEC filings for CBLL
Latest CBLL news
- CeriBell outlines $115M-$117M 2026 revenue, while launching delirium monitoring and previewing Omni for 2027 Read article
- CeriBell GAAP EPS of -$0.55 misses by $0.04, revenue of $29.3M beats by $0.14M Read article
Related companies
Opening the full analysis uses 1 of your 3 free tickers today.
Educational tool only — not investment advice.